证券记录 · 已归档季度
IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
14被追踪持有人
-2Δ持有人
98.05M持有股份
$212.78M报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -12.5% ·
股份流向 -6.2% ·
净新建仓位 -14.3%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +5 | 196.52M | $817.32M | +8 | −3 |
| Q1 2026 | 101 | +2 | 181.45M | $636.15M | +8 | −6 |
| Q4 2025 | 98 | +1 | 178.19M | $486.45M | +1 | — |
| Q3 2025 | 14 | -2 | 98.05M | $212.78M | — | −2 |
| Q2 2025 | 13 | -2 | 89.90M | $154.64M | — | −2 |
| Q1 2025 | 12 | +2 | 25.73M | $85.68M | +2 | — |
| Q4 2024 | 10 | 0 | 23.63M | $174.86M | +2 | −2 |
| Q3 2024 | 9 | -1 | 11.04M | $103.72M | +1 | −2 |
| Q2 2024 | 10 | — | 13.79M | $110.63M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (被动) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (被动) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (被动) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (被动) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (被动) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (被动) | 13.31M | +34.6% | $28.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Geode Capital Management ✦ (被动) | 6.87M | +11.0% | $14.91M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Geode Capital Management ✦ (被动) | 6.87M | +11.0% | $14.91M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 6.58M | — | $14.27M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 6.58M | — | $14.27M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Goldman Sachs Group ✦ | 6.58M | — | $14.27M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Millennium Management ✦ | 4.41M | -52.7% | $9.58M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 3.82M | -7.1% | $8.29M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 3.82M | -7.1% | $8.29M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 2.74M | -40.9% | $5.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 2.06M | -2.7% | $4.47M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 2.06M | -2.7% | $4.47M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 54 | D. E. Shaw & Co. ✦ | 76.21K | +37.4% | $165,374 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 55 | Fidelity (FMR) ✦ | 43.58K | +29.0% | $94,571 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Renaissance Technologies | $8.41M | 曾为 0.0% |
| Marshall Wace | $191,264 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 282 持有人, 266.49M 股份, $901.79M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 07
SC 13G — STATE STREET CORP
Jul 28
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据